Diagnosing and managing pleural disease

Abstract

Extract Breathe passed an exciting milestone in 2023, with the journal being awarded its inaugural journal impact factor (JIF) in the latest edition of Clarivate's Journal Citation Reports. Whilst Breathe is unlikely to have the New England Journal of Medicine , or indeed our big sister journal the European Respiratory Journal , looking over their shoulder any time soon, it certainly represents a landmark in the journal's development. There are obvious potential benefits to this: it may be institutionally important to some of our authors that they publish in journals with reportable JIFs, and Breathe is likely to become a more attractive target for submission of high-quality unsolicited educational manuscripts as a consequence of the JIF. However, it is also clear that Breathe 's mission within the European Respiratory Society (ERS) family of journals is quite distinct from building citation metrics.